If pharmaceutical companies fail to adopt patient centricity, they’ll experience losses in three major areas. ZS principal Hensley Evans provides insight as to how this will impact overall business.
If pharmaceutical companies fail to adopt patient centricity, they’ll experience losses in three major areas. ZS principal Hensley Evans provides insight as to how this will impact overall business.